Launch new drugs faster.
Find the hidden risks in your launch while there is still time to act, and get underperforming launches back on track.
How it works
- 01
You share your launch plans and history.
Launch plans and KPIs, data from your past launches, the benchmarks you hold, and IQVIA or commercial data you already license. All optional: share as much or as little as you like.
- 02
We interview at scale with voice AI.
Inside your company: brand, medical, market access, trade, reps, MSLs, and field access. Outside it: HCPs, practice staff, payers, and health systems. Hundreds of people in days, not weeks.
- 03
You get risks ranked by ROI.
What people told us, tested against your launch evidence and ranked by effect on readiness, access, and uptake, including where medical, access, and commercial teams disagree. In time to act on it.
Diagnose in the moments that matter most
Select a moment to see who we interview and the risks we find.
Pre-launch
Who we interview
- Global and country launch teams
- Brand, Medical, Regulatory, and Market Access leaders
- Sales leadership and field teams
- Payers and HCPs
Risks we find
- Teams out of alignment on messaging and the launch plan
- Critical workstreams behind schedule, including MLR, supply, and distribution
- Field or country teams not ready
- Competitor counter-messaging to the medical community ahead of launch
Start with a baseline from your past launches
Arist reviews your previous launches and interviews the teams involved: what went wrong, what affected performance, and which early signals mattered. That becomes a benchmark built for your company only, applied to your next launch. Every launch after it sharpens the benchmark, so risks surface earlier.
Institutional knowledge should stay with the institution. With Arist, the evidence and the benchmark stay yours.
Try it on a launch you’re planning
Two minutes with our agent and you’ll hear exactly what an Arist interview sounds like.